Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Protocol for a Controlled, Phase II, Multi-arm, Parallel-group, Superiority, Six-month Trial Comparing the Effectiveness of Far-UVC (222 nm) in Two Experimental Arms Against Standard Care in Preventing Viral and Bacterial Infections in Long-term Care Facilities

NCT07511881 is registered in ClinicalTrials.gov with Vejle Hospital as lead sponsor.

NCT NCT07511881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07511881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Protocol for a Controlled, Phase II, Multi-arm, Parallel-group, Superiority, Six-month Trial Comparing the Effectiveness of Far-UVC (222 nm) in Two Experimental Arms Against Standard Care in Preventing Viral and Bacterial Infections in Long-term Care Facilities
Lead sponsor
Vejle Hospital
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2024
Completion date
April 30, 2025
Enrollment
635 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infection